We would like to share ideas on the publication “Esophagitis after administration of the 1273-RNAm SARS-CoV-2 vaccine (GBS) and immune thrombocytopenic purpura (ITP) possibly induced by long COVID-19”.1 According to Velilla Moliner et al., “We suspect that the vaccine may have been the trigger of the manifested autoimmune reaction in this particular case of a patient with a personal history of atopic dermatitis, allergic rhinitis, and a childhood vaccine reaction.1” The Naranjo causality algorithm (potential causal reaction) gave the interval between the initial vaccine dose and the commencement of the clinical picture in our patient a score of 6.1 The clinical impact of the COVID-19 vaccine on other systems is highlighted by clinical medicine notwithstanding the likelihood of adverse reactions to the vaccination. It's possible or unlikely that the seizure mentioned in the current report was a harmful vaccination adverse event. Prior to vaccination, little is known about the recipient's physical, esophagogastrointestinal, or immunological state. It is challenging to make a choice because there is no clear evidence linking vaccination to esophagitis. A person who has received vaccines may also have preexisting illnesses. Additionally, the vaccine recipient can contract a separate illness. After receiving the COVID-19 vaccination, a co-infection can also manifest.2 For example, if dengue co-occur, dengue can also cause esophageal problem.3 Another prospective analysis of the COVID-19 vaccine's impact on people with full histories of esophageal exams is required. In cases where an incidence has been noted, a thorough laboratory evaluation is necessary to rule out alternative explanations.
Conflict of interestNone.
